Anesth Analg 2005;101:115-120
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000153499.10558.F3
ANESTHETIC PHARMACOLOGY
The Effect of Sildenafil on Pulmonary Embolism-Induced Oxidative Stress and Pulmonary Hypertension
Carlos A. Dias-Junior, Pharm D,
Debora C. Souza-Costa, Pharm D, MS,
Talita Zerbini,
Joao B. T. da Rocha, BS, PhD,
Raquel F. Gerlach, DDS, PhD, and
Jose E. Tanus-Santos, MD, PhD
Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil
Address correspondence and reprint requests to Jose Eduardo Tanus-Santos, MD, PhD, Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Av. Bandeirantes, 3900, 14049900 Ribeirao Preto, Sao Paulo, Brazil. Address e-mail to tanus{at}fmrp.usp.br.
Acute pulmonary embolism (APE) is a major cause of pulmonary hypertension and death. We examined the effects of sildenafil on the hemodynamic changes caused by APE in anesthetized dogs. Sham-operated dogs (n = 3) received only saline. APE was induced by stepwise IV injections of 300 µm microspheres in amounts adjusted to increase mean pulmonary artery pressures by 20 mm Hg. Hemodynamic evaluation was performed at baseline, after APE was induced, and then after sildenafil 0.25 mg/kg (n = 8), or sildenafil 1 mg/kg + 0.3 mg · kg1 · h1 (n = 8) or saline (n = 9) infusions were started. Similar experiments were conducted to examine the effects of sildenafil in rat isolated perfused lung preparation. Plasma thiobarbituric acid reactive species were also determined in both studies to measure oxidative stress. Both doses of sildenafil reduced mean pulmonary artery pressures in dogs by approximately 8 to 16 mm Hg (both P < 0.05) and attenuated the increase in oxidative stress after APE. Mean arterial blood pressure remained unaltered after both doses of sildenafil. Sildenafil produced similar effects after APE in rat isolated perfused lung preparation. These findings indicate that IV sildenafil can selectively attenuate the increases in mean pulmonary artery pressures after APE, possibly through antioxidant mechanisms.
This article has been cited by other articles:

|
 |

|
 |
 
G. Szabo, T. Radovits, G. Veres, N. Krieger, S. Loganathan, P. Sandner, and M. Karck
Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass
Eur. J. Cardiothorac. Surg.,
October 1, 2009;
36(4):
657 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Korkmaz, T. Radovits, E. Barnucz, K. Hirschberg, P. Neugebauer, S. Loganathan, G. Veres, S. Pali, B. Seidel, S. Zollner, et al.
Pharmacological Activation of Soluble Guanylate Cyclase Protects the Heart Against Ischemic Injury
Circulation,
August 25, 2009;
120(8):
677 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Haussinger and F Schliess
Pathogenetic mechanisms of hepatic encephalopathy
Gut,
August 1, 2008;
57(8):
1156 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Carlbom and B. L. Davidson
Pulmonary Embolism in the Critically Ill
Chest,
July 1, 2007;
132(1):
313 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Souza-Costa, T. Zerbini, A. C. Palei, R. F. Gerlach, and J. E. Tanus-Santos
L-arginine Attenuates Acute Pulmonary Embolism-Induced Increases in Lung Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9
Chest,
November 1, 2005;
128(5):
3705 - 3710.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|